Melius Research upgraded Oracle to Buy from Hold with a price target of $210, up from $155. The analyst does not expect every quarter to be as good as Oracle’s fiscal Q1 but says accelerating revenue growth should “be rewarded over the long-term.” The firm’s concerns have eased around the company’s margins, the sustainability of its remaining performance obligations pipeline and free cash flow. Melius sees upside to consensus estimates. Shares of Oracle are up 4% to $168.65 in morning trading.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL:
Questions or Comments about the article? Write to editor@tipranks.com